GALACTANES SULFATÉS À ACTIVITÉ ANTITHROMBOTIQUE, COMPOSITION PHARMACEUTIQUE, PROCÉDÉ DE TRAITEMENT OU DE PROPHYLAXIE DES THROMBOSES ARTÉRIELLES OU VEINEUSES, PROCÉDÉ D'EXTRACTION ET D'UTILISATION DE CES GALACTANES
The present invention relates to low molecular weight sulfated galactans, obtained from algae, particularly genus Botryocladia, preferably species Botryocladia occidentallis, which have no effect on the factor XII activation of the clotting cascade, having antithrombotic heparinoid activity. The present invention also refers to a pharmaceutical composition comprising said sulfated galactans and the use thereof, as heparin substitute, in the treatment or prophylaxis of arterial or venous thrombosis in humans and animals. Furthermore, the present invention provides a method of extraction of the said sulfated galactans.